Flow, Pressure, and Temperature Calibration: Part II - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Flow, Pressure, and Temperature Calibration: Part II


LCGC North America


Next, calculate the ratio of the length of the column at hand to the nominal column length, for which the method conditions were developed. Third, multiply by the desired average carrier gas linear velocity for the method to obtain the linear velocity goal for the specific column being installed, as shown in equation 5:






Finally, as part of verifying the setup, establish the operating or initial column temperature and then adjust the inlet pressure as required to produce the calculated velocity.

For GC systems with electronic pressure control (EPC), the EPC system will calculate and set the correct pressure for the desired velocity if the measured column length is entered first. However, slight variations in the column diameter from the nominal diameter can produce a slight error in this step. The operator can approximate the apparent column diameter at this point by comparing the measured carrier gas linear velocity to the desired value as entered into the EPC system. Because, according to equation 2, the ratio of the velocities is equal to the square of the ratio of the diameters, a corrected diameter can be calculated in this manner:







For the example given above, if the desired velocity was 32.64 cm/s for the 24 m 250 μm column, but the observed velocity was 34.9 cm/s, then the corrected column inner diameter would be:







Upon entering this corrected inner diameter into the EPC column configuration, the electronic pressure controller will adjust the pressure downward sufficiently to produce the desired average carrier-gas linear velocity. Due to the variations in inlet pressures from instrument-to-instrument, however, this procedure should be repeated whenever a column is set up.

Temperature and Pressure Calibration With a better understanding of the effects of column variability on retention times, we are in a position to examine the requirements and effects of temperature and pressure calibration in laboratories that utilize multiple gas chromatographs.

What to expect: Given that small changes in temperature or pressure can shift retention times significantly, what should gas chromatographers expect from their instrumentation? How much pressure and temperature variation is normal between gas chromatographs that are operating within the manufacturer's specifications? I read through a number of brochures, specification sheets, operator's manuals, and service manuals. I found that pressure and temperature tolerances vary somewhat by manufacturer and for some items, there was little or no information. Most GC systems produced in the past 10-15 years include provisions for oven temperature, carrier pressure, and flow calibration via the instruments' keyboard-display and firmware. Thus, gas chromatographers can bring these variables under some degree of control.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: LCGC North America,
Click here